Norsk Hydro ASA (0Q11)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 68.21 |
|---|---|
| 52-week range | 64.32 – 124.45 |
| Return, 1 month / 3 months | −20.1% / −21.7% |
| Return, 1 year / 3 years | −3.1% / +28.8% |
| Trend | Below its 200-day average |
| RSI (14) | 17 |
| Volatility (1 year) | 32.7% |
| Worst drawdown (1 year) | -42.5% |
| Average daily value traded | 24.85M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Norsk Hydro ASA is a Norwegian industrial company built around aluminium and renewable energy. It produces primary aluminium and makes rolled and extruded aluminium products, and it recycles aluminium for customers in construction, automotive, packaging and other manufacturing industries. The company also generates hydroelectric power and supplies energy to its own operations and to outside customers. Its main activities are based in Norway, with industrial operations and sales across Europe and other parts of the world.
Norsk Hydro ASA trades under the code 0Q11 on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Norsk Hydro ASA (0Q11) trades on the London Exchange in UK. It last closed at NOK 68.21 on 23 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 2,731 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.1% and over the last three months it fell 21.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -26.4% | ||
| From 52-week high | -42.5% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -21.7% | ||
| 6-month return | -35.8% | ||
| 12-month return, skipping the last month | 21.3% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.5% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 24.85M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −11.0% |
|---|---|
| 1 month | −20.1% |
| 3 months | −21.7% |
| 6 months | −35.8% |
| 1 year | −3.1% |
| 3 years | +28.8% |
| 5 years | +30.8% |
Signals
| 50-day / 200-day average | 84.93 / 92.62 |
|---|---|
| Golden / death cross (60 days) | Death, 45 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2025 | NOK 2.2500 |
| 8 May 2024 | NOK 2.5000 |
| 11 May 2023 | NOK 5.6500 |
| 21 Sep 2022 | NOK 1.4500 |
| 11 May 2022 | NOK 3.4000 |
| 7 May 2021 | NOK 1.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.